New drug discovery in the postgeno mic era: From genomics to proteomics

Journal of Clinical Psychiatry

Volumn 61, Issue 12, 2000, Pages 894-895

  Stahl, S M ^a  

^a BRAINSTORMS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CELL PROTEIN; GENE PRODUCT; NEUROKININ; NEUROLEPTIC AGENT; NEW DRUG; PROTEIN KINASE; PROTEOME; SUBSTANCE P; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; CHROMOSOME; GENE EXPRESSION; GENE MAPPING; GENETIC TRANSCRIPTION; GENOME; HUMAN; MEDICAL GENETICS; MENTAL DISEASE; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RNA SPLICING; RNA TRANSLATION; SHORT SURVEY; TARDIVE DYSKINESIA;

EID: 0034527771     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n1201     Document Type: Short Survey

References (7)

1. Introduction to the complex genetics of mental disorders
2. Peptides and psychiatry, pt 1: How synthesis of neuropeptides differs from classical neurotransmitter synthesis [Brainstorms]
3. Peptides and psychiatry, pt 2: Substance P and the neurolkinins: Novel peptide neurotransmitters in psychopharmacology [Brainstorms]
4. Placebo controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
5. Antidepressant selection in the postgenomic era
6. 3 receptor and tardive dyskinesia in chronic schizophrenia